Receptor analogues and anti-pili antibodies as inhibitors of bacterial attachment in vivo and in vitro.
D000268:Adhesiveness; D000818:Animals; D000907:Antibodies, Bacterial / Q000502:physiology*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D001667:Binding, Competitive; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000378:metabolism / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000276:immunology / Q000382:microbiology; D010861:Fimbriae, Bacterial / Q000276:immunology*; D005915:Globosides / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D051379:Mice; D011817:Rabbits; D051381:Rats; D011956:Receptors, Cell Surface; D011971:Receptors, Immunologic / Q000502:physiology*; D014552:Urinary Tract Infections / Q000276:immunology / Q000382:microbiology*; D014774:Virulence
D000907:Antibodies, Bacterial; D000911:Antibodies, Monoclonal; D005915:Globosides; D011956:Receptors, Cell Surface; D011971:Receptors, Immunologic; C033639:glycolipid receptor; C024032:globotetraosylceramide